Psychemedics Revenue 2010-2024 | PMD

Psychemedics revenue from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Psychemedics Annual Revenue
(Millions of US $)
2024 $20
2023 $22
2022 $25
2021 $25
2020 $21
2019 $38
2018 $43
2017 $40
2016 $39
2015 $27
2014 $29
2013 $27
2012 $25
2011 $24
2010 $20
2009 $17
Psychemedics Quarterly Revenue
(Millions of US $)
2024-12-31 $4
2024-09-30 $5
2024-06-30 $5
2024-03-31 $5
2023-12-31 $5
2023-09-30 $6
2023-06-30 $6
2023-03-31 $6
2022-12-31 $6
2022-09-30 $7
2022-06-30 $7
2022-03-31 $7
2021-12-31 $6
2021-09-30 $7
2021-06-30 $6
2021-03-31 $6
2020-12-31 $5
2020-09-30 $5
2020-06-30 $3
2020-03-31 $8
2019-12-31 $9
2019-09-30 $10
2019-06-30 $9
2019-03-31 $10
2018-12-31 $10
2018-09-30 $11
2018-06-30 $11
2018-03-31 $11
2017-12-31 $10
2017-09-30 $10
2017-06-30 $10
2017-03-31 $10
2016-12-31 $11
2016-09-30 $12
2016-06-30 $10
2016-03-31 $7
2015-12-31 $6
2015-09-30 $7
2015-06-30 $7
2015-03-31 $7
2014-12-31 $7
2014-09-30 $8
2014-06-30 $8
2014-03-31 $7
2013-12-31 $6
2013-09-30 $7
2013-06-30 $7
2013-03-31 $6
2012-12-31 $6
2012-09-30 $6
2012-06-30 $7
2012-03-31 $6
2011-12-31 $6
2011-09-30 $6
2011-06-30 $6
2011-03-31 $6
2010-12-31 $5
2010-09-30 $5
2010-06-30 $5
2010-03-31 $4
2009-12-31 $4
2009-09-30 $5
2009-06-30 $4
2009-03-31 $4
Sector Industry Market Cap Revenue
Medical MED-OUTP/HM CRE $0.000B $0.020B
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) US $19.865B 19.58
Encompass Health (EHC) US $11.747B 24.92
DaVita (DVA) US $10.848B 14.40
Chemed (CHE) US $8.418B 26.46
Option Care Health (OPCH) US $5.395B 24.05
Elanco Animal Health (ELAN) US $4.840B 10.71
RadNet (RDNT) US $4.004B 84.73
Amedisys (AMED) US $3.151B 21.19
LifeStance Health (LFST) US $2.644B 0.00
Addus HomeCare (ADUS) US $1.932B 22.11
Astrana Health (ASTH) US $1.822B 36.51
U.S Physical Therapy (USPH) US $1.099B 28.03
Aveanna Healthcare Holdings (AVAH) US $0.944B 0.00
Pennant (PNTG) US $0.927B 37.07
Atai Life Sciences (ATAI) DE $0.300B 0.00
Daxor (DXR) US $0.036B 0.00
Ontrak (OTRK) US $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) JP $0.005B 0.00